United States Intravenous Solutions (Colloids) Market Report & Forecast 2021-2027
Table of Contents1 Introduction to Research & Analysis Reports
1.1 Intravenous Solutions (Colloids) Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Intravenous Solutions (Colloids) Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Intravenous Solutions (Colloids) Overall Market Size
2.1 United States Intravenous Solutions (Colloids) Market Size: 2021 VS 2027
2.2 United States Intravenous Solutions (Colloids) Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Intravenous Solutions (Colloids) Sales: 2016-2027
3 Company Landscape
3.1 Top Intravenous Solutions (Colloids) Players in United States Market
3.2 Top United States Intravenous Solutions (Colloids) Companies Ranked by Revenue
3.3 United States Intravenous Solutions (Colloids) Revenue by Companies
3.4 United States Intravenous Solutions (Colloids) Sales by Companies
3.5 United States Intravenous Solutions (Colloids) Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Intravenous Solutions (Colloids) Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Intravenous Solutions (Colloids) Product Type
3.8 Tier 1, Tier 2 and Tier 3 Intravenous Solutions (Colloids) Players in United States Market
3.8.1 List of Tier 1 Intravenous Solutions (Colloids) Companies in United States
3.8.2 List of Tier 2 and Tier 3 Intravenous Solutions (Colloids) Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Intravenous Solutions (Colloids) Market Size Markets, 2021 & 2027
4.1.2 Peripheral Parenteral Nutrition
4.1.3 Total Parenteral Nutrition
4.2 By Type - United States Intravenous Solutions (Colloids) Revenue & Forecasts
4.2.1 By Type - United States Intravenous Solutions (Colloids) Revenue, 2016-2021
4.2.2 By Type - United States Intravenous Solutions (Colloids) Revenue, 2022-2027
4.2.3 By Type - United States Intravenous Solutions (Colloids) Revenue Market Share, 2016-2027
4.3 By Type - United States Intravenous Solutions (Colloids) Sales & Forecasts
4.3.1 By Type - United States Intravenous Solutions (Colloids) Sales, 2016-2021
4.3.2 By Type - United States Intravenous Solutions (Colloids) Sales, 2022-2027
4.3.3 By Type - United States Intravenous Solutions (Colloids) Sales Market Share, 2016-2027
4.4 By Type - United States Intravenous Solutions (Colloids) Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Intravenous Solutions (Colloids) Market Size, 2021 & 2027
5.1.2 Hospital and Clinics
5.1.3 Ambulatory
5.1.4 Home Care
5.2 By Application - United States Intravenous Solutions (Colloids) Revenue & Forecasts
5.2.1 By Application - United States Intravenous Solutions (Colloids) Revenue, 2016-2021
5.2.2 By Application - United States Intravenous Solutions (Colloids) Revenue, 2022-2027
5.2.3 By Application - United States Intravenous Solutions (Colloids) Revenue Market Share, 2016-2027
5.3 By Application - United States Intravenous Solutions (Colloids) Sales & Forecasts
5.3.1 By Application - United States Intravenous Solutions (Colloids) Sales, 2016-2021
5.3.2 By Application - United States Intravenous Solutions (Colloids) Sales, 2022-2027
5.3.3 By Application - United States Intravenous Solutions (Colloids) Sales Market Share, 2016-2027
5.4 By Application - United States Intravenous Solutions (Colloids) Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 ICU Medical Inc.
6.1.1 ICU Medical Inc. Corporation Information
6.1.2 ICU Medical Inc. Overview
6.1.3 ICU Medical Inc. Intravenous Solutions (Colloids) Sales and Revenue in United States Market (2016-2021)
6.1.4 ICU Medical Inc. Intravenous Solutions (Colloids) Product Description
6.1.5 ICU Medical Inc. Recent Developments
6.2 B. Braun Melsungen AG
6.2.1 B. Braun Melsungen AG Corporation Information
6.2.2 B. Braun Melsungen AG Overview
6.2.3 B. Braun Melsungen AG Intravenous Solutions (Colloids) Sales and Revenue in United States Market (2016-2021)
6.2.4 B. Braun Melsungen AG Intravenous Solutions (Colloids) Product Description
6.2.5 B. Braun Melsungen AG Recent Developments
6.3 Fresenius Kabi AG
6.3.1 Fresenius Kabi AG Corporation Information
6.3.2 Fresenius Kabi AG Overview
6.3.3 Fresenius Kabi AG Intravenous Solutions (Colloids) Sales and Revenue in United States Market (2016-2021)
6.3.4 Fresenius Kabi AG Intravenous Solutions (Colloids) Product Description
6.3.5 Fresenius Kabi AG Recent Developments
6.4 Baxter
6.4.1 Baxter Corporation Information
6.4.2 Baxter Overview
6.4.3 Baxter Intravenous Solutions (Colloids) Sales and Revenue in United States Market (2016-2021)
6.4.4 Baxter Intravenous Solutions (Colloids) Product Description
6.4.5 Baxter Recent Developments
6.5 Amanta Healthcare
6.5.1 Amanta Healthcare Corporation Information
6.5.2 Amanta Healthcare Overview
6.5.3 Amanta Healthcare Intravenous Solutions (Colloids) Sales and Revenue in United States Market (2016-2021)
6.5.4 Amanta Healthcare Intravenous Solutions (Colloids) Product Description
6.5.5 Amanta Healthcare Recent Developments
6.6 Terumo Medical Corporation
6.6.1 Terumo Medical Corporation Corporation Information
6.6.2 Terumo Medical Corporation Overview
6.6.3 Terumo Medical Corporation Intravenous Solutions (Colloids) Sales and Revenue in United States Market (2016-2021)
6.6.4 Terumo Medical Corporation Intravenous Solutions (Colloids) Product Description
6.6.5 Terumo Medical Corporation Recent Developments
6.7 Grifols S.A.
6.7.1 Grifols S.A. Corporation Information
6.7.2 Grifols S.A. Overview
6.7.3 Grifols S.A. Intravenous Solutions (Colloids) Sales and Revenue in United States Market (2016-2021)
6.7.4 Grifols S.A. Intravenous Solutions (Colloids) Product Description
6.7.5 Grifols S.A. Recent Developments
7 United States Intravenous Solutions (Colloids) Production Capacity, Analysis
7.1 United States Intravenous Solutions (Colloids) Production Capacity, 2016-2027
7.2 Intravenous Solutions (Colloids) Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Intravenous Solutions (Colloids) Supply Chain Analysis
9.1 Intravenous Solutions (Colloids) Industry Value Chain
9.2 Intravenous Solutions (Colloids) Upstream Market
9.3 Intravenous Solutions (Colloids) Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Intravenous Solutions (Colloids) Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of TablesTable 1. Key Players of Intravenous Solutions (Colloids) in United States Market
Table 2. Top Intravenous Solutions (Colloids) Players in United States Market, Ranking by Revenue (2019)
Table 3. United States Intravenous Solutions (Colloids) Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States Intravenous Solutions (Colloids) Revenue Share by Companies, 2016-2021
Table 5. United States Intravenous Solutions (Colloids) Sales by Companies, (K Units), 2016-2021
Table 6. United States Intravenous Solutions (Colloids) Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Intravenous Solutions (Colloids) Price (2016-2021) & (USD/Unit)
Table 8. Manufacturers Intravenous Solutions (Colloids) Product Type
Table 9. List of Tier 1 Intravenous Solutions (Colloids) Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Intravenous Solutions (Colloids) Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Peripheral Parenteral Nutrition
Table 12. Major Manufacturers of Total Parenteral Nutrition
Table 13. By Type - United States Intravenous Solutions (Colloids) Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States Intravenous Solutions (Colloids) Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States Intravenous Solutions (Colloids) Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States Intravenous Solutions (Colloids) Sales (K Units), 2016-2021
Table 17. By Type - United States Intravenous Solutions (Colloids) Sales (K Units), 2022-2027
Table 18. By Application - United States Intravenous Solutions (Colloids) Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States Intravenous Solutions (Colloids) Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States Intravenous Solutions (Colloids) Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States Intravenous Solutions (Colloids) Sales (K Units), 2016-2021
Table 22. By Application - United States Intravenous Solutions (Colloids) Sales (K Units), 2022-2027
Table 23. ICU Medical Inc. Corporation Information
Table 24. ICU Medical Inc. Description and Major Businesses
Table 25. ICU Medical Inc. Intravenous Solutions (Colloids) Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 26. ICU Medical Inc. Intravenous Solutions (Colloids) Product
Table 27. ICU Medical Inc. Recent Developments
Table 28. B. Braun Melsungen AG Corporation Information
Table 29. B. Braun Melsungen AG Description and Major Businesses
Table 30. B. Braun Melsungen AG Intravenous Solutions (Colloids) Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 31. B. Braun Melsungen AG Intravenous Solutions (Colloids) Product
Table 32. B. Braun Melsungen AG Recent Developments
Table 33. Fresenius Kabi AG Corporation Information
Table 34. Fresenius Kabi AG Description and Major Businesses
Table 35. Fresenius Kabi AG Intravenous Solutions (Colloids) Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 36. Fresenius Kabi AG Intravenous Solutions (Colloids) Product
Table 37. Fresenius Kabi AG Recent Developments
Table 38. Baxter Corporation Information
Table 39. Baxter Description and Major Businesses
Table 40. Baxter Intravenous Solutions (Colloids) Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 41. Baxter Intravenous Solutions (Colloids) Product
Table 42. Baxter Recent Developments
Table 43. Amanta Healthcare Corporation Information
Table 44. Amanta Healthcare Description and Major Businesses
Table 45. Amanta Healthcare Intravenous Solutions (Colloids) Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 46. Amanta Healthcare Intravenous Solutions (Colloids) Product
Table 47. Amanta Healthcare Recent Developments
Table 48. Terumo Medical Corporation Corporation Information
Table 49. Terumo Medical Corporation Description and Major Businesses
Table 50. Terumo Medical Corporation Intravenous Solutions (Colloids) Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 51. Terumo Medical Corporation Intravenous Solutions (Colloids) Product
Table 52. Terumo Medical Corporation Recent Developments
Table 53. Grifols S.A. Corporation Information
Table 54. Grifols S.A. Description and Major Businesses
Table 55. Grifols S.A. Intravenous Solutions (Colloids) Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 56. Grifols S.A. Intravenous Solutions (Colloids) Product
Table 57. Grifols S.A. Recent Developments
Table 58. Intravenous Solutions (Colloids) Production Capacity (K Units) of Key Manufacturers in United States Market, 2019-2021 (K Units)
Table 59. United States Intravenous Solutions (Colloids) Capacity Market Share of Key Manufacturers, 2019-2021
Table 60. Intravenous Solutions (Colloids) Market Opportunities & Trends in United States Market
Table 61. Intravenous Solutions (Colloids) Market Drivers in United States Market
Table 62. Intravenous Solutions (Colloids) Market Restraints in United States Market
Table 63. Intravenous Solutions (Colloids) Raw Materials
Table 64. Intravenous Solutions (Colloids) Raw Materials Suppliers in United States Market
Table 65. Typical Intravenous Solutions (Colloids) Downstream
Table 66. Intravenous Solutions (Colloids) Downstream Clients in United States Market
Table 67. Intravenous Solutions (Colloids) Distributors and Sales Agents in United States Market
List of FiguresFigure 1. Intravenous Solutions (Colloids) Product Picture
Figure 2. Intravenous Solutions (Colloids) Segment by Type
Figure 3. Intravenous Solutions (Colloids) Segment by Application
Figure 4. United States Intravenous Solutions (Colloids) Market Overview: 2020
Figure 5. United States Intravenous Solutions (Colloids) Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States Intravenous Solutions (Colloids) Revenue, 2016-2027 (US$, Mn)
Figure 7. Intravenous Solutions (Colloids) Sales in United States Market: 2016-2027 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Intravenous Solutions (Colloids) Revenue in 2020
Figure 9. Peripheral Parenteral Nutrition Product Picture
Figure 10. Total Parenteral Nutrition Product Picture
Figure 11. By Type - United States Intravenous Solutions (Colloids) Sales Market Share, 2016-2027
Figure 12. By Type - United States Intravenous Solutions (Colloids) Revenue Market Share, 2016-2027
Figure 13. By Type - United States Intravenous Solutions (Colloids) Price (USD/Unit), 2016-2027
Figure 14. Hospital and Clinics
Figure 15. Ambulatory
Figure 16. Home Care
Figure 17. By Application - United States Intravenous Solutions (Colloids) Sales Market Share, 2016-2027
Figure 18. By Application - United States Intravenous Solutions (Colloids) Revenue Market Share, 2016-2027
Figure 19. By Application - United States Intravenous Solutions (Colloids) Price (USD/Unit), 2016-2027
Figure 20. ICU Medical Inc. Intravenous Solutions (Colloids) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. B. Braun Melsungen AG Intravenous Solutions (Colloids) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. Fresenius Kabi AG Intravenous Solutions (Colloids) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Baxter Intravenous Solutions (Colloids) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Amanta Healthcare Intravenous Solutions (Colloids) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Terumo Medical Corporation Intravenous Solutions (Colloids) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Grifols S.A. Intravenous Solutions (Colloids) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. United States Intravenous Solutions (Colloids) Production Capacity (K Units), 2016-2027
Figure 28. Intravenous Solutions (Colloids) Industry Value Chain
Figure 29. Marketing Channels